A system personalized to you

When you turn to DBS, you’re taking control of your Parkinson's disease (PD) diagnosis. This is a brave decision backed by research, conversations with family, doctors, and loved ones. We don’t take your interest in Boston Scientific lightly and want to demonstrate the differences in our DBS solution, so you can make an informed decision about your care.

Combining Multiple Independent Current Control (MICC) and novel directional capabilities, the Vercise Genus™ DBS System offers unprecedented control for improved patient outcomes.

The Boston Scientific difference

Boston Scientific’s Vercise™ Directional DBS Systems* provide your doctor sensitive and precise ways to manage your needs and adapt as your symptoms change over time.

Our MICC technology makes us uniquely capable of delivering precise therapy by pairing directional leads with a stimulator that independently powers each electrode on the lead. Our Image Guided Programming enables your physician to see the exact location of your leads and deliver personalized therapy to you. Regardless of how your symptoms change over time, your Boston Scientific DBS system will follow and create more opportunities for your therapy to be effective.1

Note: Stimulation using multiple independent current control (MICC) with a Direcitonal Lead is referred to as Cartesia™ 3D

The science behind our systems

At Boston Scientific, research and clinical evidence are vital to how we make decisions, evaluate our technology, and continue to advance our field. Accordingly, we conducted a multicenter, prospective, double blinded, randomized, trial for those living with DBS at their one-year follow-up, called the INTREPID study.2

1 year into treatment, Boston Scientific DBS patients experienced a 51% improvement in their motor function2

At the end of 1 year, the Boston Scientific patient achieved 6 additional hours of good quality "ON time" each day, compared to their best treatment before DBS2

DBS patients with a Boston Scientific system experienced meaningful improvements in their quality of life2

1 year into treatment, Boston Scientific DBS patients reported a 30% decrease in medication usage2

See how Directional DBS targets your PD symptoms

Charging your life

Many DBS devices require a surgery to replace the battery every 3-5 years.3 Our rechargeable battery Vercise Genus R16 System is warrantied for up to 15 years.

Unparalleled comfort

Both of our Vercise Genus™ DBS Systems have gently contoured edges for comfort. The Vercise Genus P16 System is the thinnest non-rechargeable battery available.

Vercise Genus™ R16 System

  • Smallest DBS stimulator
  • Rechargeable
  • Warrantied for up to 15 years
  • Powered by Cartesia™ 3D technology
  • Bluetooth® wireless remote connectivity**
  • Full body MRI access***

Vercise Genus™ P16 System

  • Thinnest, non-rechargeable, dual channel DBS Stimulator
  • Lasts a minimum of 3 years with nominal settings
  • Powered by Cartesia 3D technology
  • Bluetooth® wireless remote connectivity**
  • Full body MRI access***

Note: Stimulation using multiple independent current control (MICC) with a Directional Lead is referred to as Cartesia 3D

Hear from the experts

Dr. Jerold Vitek, Professor and Chair, Department of Neurology, University of Minnesota, talks about the difference of the Vercise™ DBS System.

Help us connect you to the right resources and specialists.

Answer a few short questions. Take the quiz now. ⟶